Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06363578
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-04-09
Brief Title:
Different Doses of Dexmedetomidine in External Oblique Intercostal Plane Block in Splenectomy
Sponsor:
Tanta University
Organization:
Tanta University
Study Overview
Official Title:
Comparing the Analgesic Effects of Different Doses of Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block in Splenectomy A Randomized Trial
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to compare the analgesic effects of different doses of dexmedetomidine as an adjuvant in external oblique intercostal plane block EOIPB in splenectomy
Detailed Description:
External oblique intercostal plane block EOIPB was reported by Elsharkawy et al It is a novel block which has been described as an important modification of the fascial plane blocks that can consistently involve the upper lateral abdominal walls In comparison to quadratus lumborum block QLB and erector spinae plane block ESPB EOIPB has the benefit of being performed when the patient is supine It also has an advantage over serratus intercostal plane block SIPB in that it produces greater analgesia throughout the midline of the abdomen
Dexmedetomidine is used for sedation in patients admitted to the intensive care unit ICU Dexmedetomidine is a selective alpha 2- adrenoceptor agonist possessing sedative anxiolytic and analgesic properties without the development of respiratory depression Several studies have shown that dexmedetomidine has an anesthetic sparing effect which has led to its use as a general adjuvant for prolonging peripheral nerve block duration
Dexmedetomidine is used for sedation in patients admitted to the intensive care unit ICU Dexmedetomidine is a selective alpha 2- adrenoceptor agonist possessing sedative anxiolytic and analgesic properties without the development of respiratory depression Several studies have shown that dexmedetomidine has an anesthetic sparing effect which has led to its use as a general adjuvant for prolonging peripheral nerve block duration
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None